The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity.
Open accessAbstract
The closely related multidrug efflux pumps QacA and QacB, from the bacterial pathogen Staphylococcus aureus, both confer resistance to various toxic organic cations but differ in that QacB mediates lower levels of resistance to divalent cations. Cloning and nucleotide sequencing of the qacB gene revealed that qacB differs from qacA by only seven nucleotide substitutions. Random hydroxylamine mutagenesis of qacB was undertaken, selecting for variants that conferred increased resistance to divalent cations. Both QacA and the QacB mutants capable of conferring resistance to divalent cations contain an acidic residue at either amino acid 322 or 323, whereas QacB contains uncharged residues in these positions. Site-directed mutagenesis of qacA confirmed the importance of an acidic residue within this region of QacA in conferring resistance to divalent cations. Membrane topological analysis using alkaline phosphatase and beta-galactosidase fusions indicated that the QacA protein contains 14 transmembrane segments. Thus, QacA represents the first membrane transport protein shown to contain 14 transmembrane segments, and confirms that the major facilitator superfamily contains a family of proteins with 14 transmembrane segments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Yanisch-Perron, C., Vieira, J., & Messing, J. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 15,041
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
[19] Rapid and efficient site-specific mutagenesis without phenotypic selection
Kunkel, T. A., Roberts, J. D., & Zakour, R. A. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)54085-x · Cited by 5,261
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
[1] Production of single-stranded plasmid DNA
Vieira, J., & Messing, J. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)53044-0 · Cited by 2,597
Membrane protein structure prediction
von Heijne, G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90934-c · Cited by 1,676
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
λ ZAP: a bacteriophage λ expression vector with in vivo excision properties
Short, J. M., Fernandez, J. M., Sorge, J. A., & Huse, W. D. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.15.7583 · Cited by 1,365
TnphoA: a transposon probe for protein export signals.
Manoil, C., & Beckwith, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8129 · Cited by 1,013
Cited by
Antiseptics and Disinfectants: Activity, Action, and Resistance
McDonnell, G., & Russell, A. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.147 · Cited by 4,780
Proton-dependent multidrug efflux systems
Paulsen, I. T., Brown, M. H., & Skurray, R. A. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.4.575-608.1996 · Cited by 1,198
Self-citationThe TetR Family of Transcriptional Repressors
Ramos, J. L., Martínez-Bueno, M., Molina-Henares, A. J., Terán, W., Watanabe, K., Zhang, X., Gallegos, M. T., Brennan, R., & Tobes, R. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.326-356.2005 · Cited by 1,103
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Molecular Properties of Bacterial Multidrug Transporters
Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 795
Jennings, M. C., Minbiole, K. P. C., & Wuest, W. M. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00047 · Cited by 651
“Closely related to QacA is QacB, which shares a high degree of homology - only seven nucleotides differ between qacA and qacB - yet is more specific in recognizing monoQACs due to the presence of an uncharged residue, alanine, instead of aspartic acid as found in QacA.(92) It has been shown that mutation of this alani…”
BackgroundInfluentialBuffet-Bataillon, S., Tattevin, P., Bonnaure-Mallet, M., & Jolivet-Gougeon, A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.01.011 · Cited by 601
Mechanisms of RND multidrug efflux pumps
Nikaido, H., & Takatsuka, Y. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.10.004 · Cited by 555
Bacterial resistance to antibiotics: Active efflux and reduced uptake
KUMAR, A., & SCHWEIZER, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.004 · Cited by 529
Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems
Martinez, J. L., Sánchez, M. B., Martínez-Solano, L., Hernandez, A., Garmendia, L., Fajardo, A., & Alvarez-Ortega, C. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00157.x · Cited by 491
Mechanisms of fluoroquinolone resistance
Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488
The major facilitator superfamily (MFS) revisited
Reddy, V. S., Shlykov, M. A., Castillo, R., Sun, E. I., & Saier, M. H. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08588.x · Cited by 476
Multidrug resistance mechanisms: drug efflux across two membranes
Zgurskaya, H. I., & Nikaido, H. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01926.x · Cited by 466
Structures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS)
Drew, D., North, R. A., Nagarathinam, K., & Tanabe, M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00983 · Cited by 465
Regulation of bacterial drug export systems
Grkovic, S., Brown, M. H., & Skurray, R. A. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.4.671-701.2002 · Cited by 423
Self-citationMultidrug Efflux Pumps in Staphylococcus aureus: an Update
Costa, S. S., Viveiros, M., Amaral, L., & Couto, I. (2013) · The Open Microbiology Journal · doi:10.2174/1874285801307010059 · Cited by 409
Hegstad, K., Langsrud, S., Lunestad, B. T., Scheie, A. A., Sunde, M., & Yazdankhah, S. P. (2010) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0120 · Cited by 396
Edgar, R., & Bibi, E. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.7.2274-2280.1997 · Cited by 384
Kampf, G. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.018 · Cited by 370
Structural Mechanisms of QacR Induction and Multidrug Recognition
Schumacher, M. A., Miller, M. C., Grkovic, S., Brown, M. H., Skurray, R. A., & Brennan, R. G. (2001) · Science · doi:10.1126/science.1066020 · Cited by 368
Self-citationQuaternary ammonium salts and their antimicrobial potential: targets or nonspecific interactions
Tischer, M., Pradel, G., Ohlsen, K., & Holzgrabe, U. (2012) · ChemMedChem · doi:10.1002/cmdc.201100404 · Cited by 357
Gilbert, P., & McBain, A. J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.189-208.2003 · Cited by 334
Role of mycobacterial efflux transporters in drug resistance: an unresolved question
Rossi, E. D., Aínsa, J. A., & Riccardi, G. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2005.00002.x · Cited by 328
Modes of action of three disinfectant active substances: A review
Wessels, S., & Ingmer, H. (2013) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2013.09.006 · Cited by 297
Multiple antibiotic resistance and efflux
Nikaido, H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80083-0 · Cited by 301
Paulsen, I. T., Sliwinski, M. K., & Saier, M. H. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1609 · Cited by 295
Self-citationKaatz, G. W., McAleese, F., & Seo, S. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1857-1864.2005 · Cited by 279
Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?
Horner, C., Mawer, D., & Wilcox, M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks284 · Cited by 278
Evolutionary origins of multidrug and drug‐specific efflux pumps in bacteria
Saier, M. H., Paulsen, I. T., Marek, K. S., Pao, S. S., Ronald, A. S., & Nikaido, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.03.265 · Cited by 263
Self-citationA Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
Louw, G. E., Warren, R. M., Gey van Pittius, N. C., McEvoy, C. R. E., Van Helden, P. D., & Victor, T. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01577-08 · Cited by 263
Ortega Morente, E., Fernández-Fuentes, M. A., Grande Burgos, M. J., Abriouel, H., Pérez Pulido, R., & Gálvez, A. (2013) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2012.12.028 · Cited by 254
Bayer, A. S., Prasad, R., Chandra, J., Koul, A., Smriti, M., Varma, A., Skurray, R. A., Firth, N., Brown, M. H., Koo, S.-P., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3548-3553.2000 · Cited by 150
Metadata
- Authors
- Paulsen, I. T., Brown, M. H., Littlejohn, T. G., Mitchell, B. A., & Skurray, R. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-04-16
- Volume
- 93
- Issue
- 8
- Pages
- 3630-3635
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2071251528
- Cited by
- 291
- References
- 35
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.